Modern Pharmaceutical (MRNA) – Get report, one of the leading candidates to produce a viable coronavirus vaccine, fell on Monday after Oxford University and AstraZeneca (AZN) – Get report published promising data from an early-stage trial of a key coronavirus vaccine study, and the population received a downgrade from JP …
Read More »Moderna Shares Report of Delayed Coronavirus Trial
Moderna’s MRNA shares were lower after a news report said biotechnology was delaying the start of a Phase III trial of its experimental coronavirus vaccine. Shares of the Cambridge, Massachusetts company in the latest check fell 5.4% to $ 58.25. Healthcare website Stat News said Moderna was making changes to …
Read More »Vaccine maker ETF rises to Trump’s positive proclamation
Vaccine makers were climbing during Thursday’s volatile market session when investors took President Trump’s bullish proclamation on Wednesday that a vaccine to treat COVID-19 is closer than many expected to hear. Inovio Pharmaceuticals (INO) – Get report jumped more than 17% on Thursday, while Sorrento (SRNE) – Get report Almost …
Read More »